Left ventricular (LV) systolic dysfunction means the heart’s main pumping chamber, the left ventricle, cannot squeeze forcefully enough to push blood out to the body. Doctors typically identify it by measuring the ejection fraction, a number representing what percentage of blood the left ventricle ejects with each beat; when that number falls below the normal range, systolic function is considered impaired. The causes span a wide spectrum, from heart attacks and chronic high blood pressure to genetic conditions, infections, and even certain cancer drugs. What makes the topic more interesting than a simple list of culprits is that the body’s own attempts to compensate for a weakening heart often accelerate the damage, and some causes are entirely reversible if caught in time.
What Happens Inside a Weakening Heart
When the left ventricle starts losing pumping strength, the body detects a drop in blood output and launches a rescue response. The sympathetic nervous system ramps up, flooding the heart with adrenaline-like signals to beat harder and faster. At the same time, the kidneys activate the renin-angiotensin-aldosterone system (RAAS), which retains salt and water to increase blood volume and tightens blood vessels to maintain blood pressure. In the short term, these responses keep organs perfused. Over weeks and months, though, they become part of the problem: the constant hormonal stimulation stresses the heart muscle, promotes scarring, and causes the ventricle to enlarge and stiffen in a process called remodeling.1PubMed Central. Neurohormonal activation in heart failure with reduced ejection fraction
At the cellular level, another key breakdown involves calcium handling. Heart muscle cells rely on tightly controlled calcium flow to contract and relax with each heartbeat. In a failing heart, the machinery that moves calcium into and out of muscle cells becomes disrupted, so contractions grow weaker and more irregular.2PubMed Central. Mechanisms of altered Ca²⁺ handling in heart failure Several factors contribute to this: the channels that trigger calcium release may not work properly, the internal calcium stores run low, and the coupling between the electrical signal and the mechanical squeeze becomes less efficient.3The Journal of Clinical Investigation. Altered intracellular Ca2+ handling in heart failure This calcium dysfunction is both a consequence and a driver of worsening systolic performance, and it helps explain why the failing heart is also prone to dangerous rhythm disturbances.
Understanding that the body’s compensatory systems eventually do more harm than good was a pivotal insight. Before the 1980s, heart failure was treated mainly as a plumbing problem: the pump was weak, so doctors tried to make it pump harder with stimulant drugs. The shift to viewing heart failure as a neuroendocrine disease led to the modern drug therapies that block those harmful hormonal cascades rather than whip the tired heart into working harder.4PubMed Central. Diagnosis History of Heart Failure Definition
Coronary Artery Disease and Heart Attacks
Blocked coronary arteries remain the single most common reason people develop LV systolic dysfunction. When a heart attack cuts off blood flow to a section of the left ventricle, the muscle cells in that region can die within hours. Dead muscle is replaced by scar tissue, which cannot contract at all. A large enough area of damage, or repeated smaller events, leaves the ventricle unable to generate adequate pumping force. Patients with a prior history of coronary artery disease and previous procedures to open blocked arteries are at substantially higher risk of severe LV dysfunction if they suffer another heart attack.5PubMed Central. Severe Left Ventricular Dysfunction Earlier after Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
Not all heart muscle affected by poor blood flow is permanently lost, though. Cardiologists distinguish between two potentially salvageable states. “Stunned” muscle has adequate blood supply but is still recovering from a temporary injury, while “hibernating” muscle has chronically reduced blood flow and has essentially gone into a low-energy standby mode to survive.6PubMed. Time course of functional recovery of stunned and hibernating segments after surgical revascularization In both cases, restoring good blood flow through bypass surgery or stenting can wake those segments back up and improve overall ejection fraction. That possibility is one reason doctors are so eager to determine whether areas of poor contraction represent dead scar or viable but sleeping muscle.
Chronic High Blood Pressure
Hypertension forces the left ventricle to work harder with every beat, pushing blood against elevated pressure in the arteries. Over years, the muscle wall thickens to handle the extra load, a change called left ventricular hypertrophy. For a while, the thickened wall maintains normal pumping. Eventually, though, the adaptation breaks down. The thickened muscle outgrows its blood supply, stiffens, and begins to fail.7PubMed Central. From hypertension to heart failure Data from a large treatment trial confirmed this progression, showing that chronic pressure overload can lead to an enlarged heart and overt systolic dysfunction even in patients who are receiving blood-pressure medications.8Exploration of Medicine. Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy
Hypertension also promotes coronary artery disease, so it can damage the heart through two paths at once: directly straining the muscle and indirectly starving it of blood. That dual threat is why aggressive blood-pressure control is one of the most effective ways to prevent systolic dysfunction from developing in the first place.
Valve Disease
Heart valves that don’t open or close properly create mechanical loads the left ventricle was never designed to handle long-term. Aortic stenosis, where the aortic valve becomes narrowed and stiff, forces the ventricle to generate much higher pressures to push blood through the tight opening. Initially the muscle thickens and compensates, but over time, cell death and scarring in the muscle tissue tip the balance toward reduced ejection fraction.9PubMed Central. Left Ventricular Systolic Dysfunction in Aortic Stenosis Even after valve replacement surgery, patients whose systolic function has already declined tend to have worse outcomes than those who had surgery before the ventricle weakened.
Leaky valves cause a different kind of stress. Mitral regurgitation, for example, lets blood leak backward into the left atrium with each beat, forcing the ventricle to pump extra volume to deliver the same net output. A multicenter study found that patients with significant mitral valve leakage and an ejection fraction below 60% had markedly higher mortality compared with those above that threshold, and those with ejection fractions below 45% faced roughly two and a half times the risk of death.10PubMed. Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets This finding is worth noting because an ejection fraction of 55% or even 50% might look “normal” on paper in other contexts, yet in the setting of a leaky mitral valve, the ventricle should be hyperdynamic to compensate. A number that looks average is actually a sign of muscle failure.
Dilated Cardiomyopathy and Genetics
Sometimes the heart muscle weakens without any blocked arteries, valve problems, or high blood pressure to blame. Dilated cardiomyopathy (DCM) is a condition where the left ventricle balloons out and loses contractile strength. A significant share of DCM cases run in families, and the most common genetic culprit involves the gene for titin, the largest protein in the human body. Titin acts as a molecular spring inside each muscle cell, and truncating mutations in the titin gene (TTNtv) are the leading heritable cause of DCM.11PubMed. Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene
A landmark study using genetic sequencing found TTN mutations in about 27% of patients with dilated cardiomyopathy, compared with only about 3% of healthy controls. These mutations showed high penetrance after the age of 40, meaning most carriers eventually developed the disease if they lived long enough.12PubMed Central. Truncations of titin causing dilated cardiomyopathy The complicating factor is that some people carry these truncating variants and remain asymptomatic, making genetic counseling and risk prediction difficult.13PubMed Central. Titin Cardiomyopathy, Emerging Evidence: More Than A Big Heart Genetic testing for DCM has grown rapidly in clinical practice, but interpreting the results still requires nuance. A positive result does not guarantee heart failure will develop, and a negative result does not rule out a genetic component.
Infections and Inflammation
Viral myocarditis, an inflammation of the heart muscle triggered by infection, is a well-recognized cause of dilated cardiomyopathy worldwide.14PubMed Central. Diagnosis and treatment of viral myocarditis The viruses responsible have shifted over the decades: enteroviruses like Coxsackie B dominated in earlier eras, while parvovirus B19 and human herpesvirus-6 became more commonly identified in later studies. More recently, COVID-19 added another virus to the list, though the exact frequency and mechanism of cardiac involvement remain areas of active research.
Myocarditis can be tricky to diagnose because its symptoms, including chest pain, shortness of breath, and fatigue, overlap with many other conditions. Some people experience a dramatic acute illness with a sharp drop in ejection fraction, while others have a smoldering course that mimics idiopathic DCM. The degree of left and right ventricular dysfunction at presentation is one of the most important factors predicting long-term outcomes. Some patients recover fully; others progress to chronic heart failure needing transplant evaluation.
Toxic and Drug-Induced Damage
Certain substances are directly poisonous to heart muscle cells. The most clinically significant examples are anthracycline chemotherapy drugs like doxorubicin, widely used against leukemias, lymphomas, and breast cancer. Anthracycline cardiotoxicity can appear during treatment, within the first year afterward, or in rare cases, surface years later. One reported case involved sudden heart failure seven years after chemotherapy was completed.15PubMed Central. Delayed Onset Anthracycline-Associated Cardiotoxicity Presenting as Acute Decompensated Heart Failure Seven Years After Chemotherapy Completion Risk factors for developing this complication include concurrent use of the targeted therapy trastuzumab, having diabetes, and heavy alcohol consumption.16PubMed Central. Risk factors for anthracycline-associated cardiotoxicity
Alcohol itself, independent of chemotherapy, is a classic cause of toxic cardiomyopathy when consumed heavily over a long period. The damage is dose-dependent and, if caught early enough, can partially reverse with sustained abstinence. Cocaine and methamphetamine can also cause acute and chronic systolic dysfunction through direct toxicity, coronary spasm, and sustained sympathetic stimulation. Illicit drug use is an underappreciated cause of heart failure in younger adults.
Stress Cardiomyopathy and Hormonal Causes
Takotsubo cardiomyopathy, sometimes called “broken heart syndrome,” is a dramatic example of how overwhelming emotional or physical stress can temporarily cripple the left ventricle. The hallmark pattern involves ballooning and paralysis of the middle and tip of the ventricle while the base continues to squeeze, giving the heart a shape resembling a Japanese octopus trap (tako-tsubo). The most favored explanation is that a massive surge of stress hormones stuns the heart muscle.17PubMed. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction Coronary arteries are typically clean on angiography, which distinguishes takotsubo from a true heart attack. The condition is most common in postmenopausal women and usually reverses within days to weeks, though severe cases can be life-threatening in the acute phase.
Endocrine disorders can also erode systolic function over time. An overactive thyroid gland drives the heart rate up chronically and can lead to high-output heart failure or atrial fibrillation, both of which strain the left ventricle. An underactive thyroid tends to cause diastolic problems and accelerate atherosclerosis. Diabetes mellitus induces its own form of cardiomyopathy through small-vessel injury and oxidative stress, affecting both how the heart squeezes and how it relaxes. Other hormonal conditions, including excess growth hormone (acromegaly) and catecholamine-secreting tumors like pheochromocytoma, can directly alter cardiac structure and function.18PubMed Central. Cardiomyopathies of endocrine origin: A state-of-the-art review
Peripartum Cardiomyopathy
A cause that catches many people off guard is peripartum cardiomyopathy, systolic heart failure that develops in the final month of pregnancy or within several months of delivery. It tends to affect otherwise healthy young women with no prior heart disease. Incidence is higher among African-American women, women with pregnancy-related hypertension, those with older maternal age, and those carrying multiples.19PubMed. Peripartum Cardiomyopathy: JACC State-of-the-Art Review Research over the past decade points to vascular dysfunction triggered by hormones in late pregnancy, and more recent evidence suggests many cases have a genetic component as well.20PubMed. Peripartum Cardiomyopathy Recovery rates vary widely. Some women regain full heart function within months; others progress to severe chronic heart failure requiring transplant.
Causes That Can Be Reversed
One of the most encouraging aspects of LV systolic dysfunction is that not all cases are permanent. Arrhythmia-induced cardiomyopathy is a condition where sustained fast or irregular heart rhythms gradually weaken the ventricle, but once the rhythm problem is controlled, pumping function can partially or completely recover.21PubMed Central. Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management Common offenders include atrial fibrillation, sustained rapid heart rates from other causes, and even frequent premature ventricular contractions when they occur thousands of times per day.22PubMed Central. Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review
The clinical challenge is figuring out which came first: did the arrhythmia cause the weak heart, or did the weak heart cause the arrhythmia? The distinction matters enormously because arrhythmia-induced cardiomyopathy is one of the few forms where treating the rhythm disorder alone can restore the ejection fraction to near-normal. A person mistakenly assumed to have irreversible DCM might actually have a curable rhythm problem driving the whole picture. Other potentially reversible triggers include thyroid disease, takotsubo (as discussed above), alcoholic cardiomyopathy with abstinence, and tachycardia-induced cardiomyopathy from any cause of persistently elevated heart rate.23PubMed Central. Tachycardia-induced Cardiomyopathy (Tachycardiomyopathy)
When There Are No Symptoms
A reduced ejection fraction does not always announce itself with obvious symptoms. Asymptomatic LV systolic dysfunction, classified as stage B heart failure, refers to people whose ventricle is already weakened but who do not yet have the shortness of breath, fatigue, or fluid retention that define clinical heart failure.24PubMed Central. Asymptomatic Left Ventricle Systolic Dysfunction This silent stage is more common than many people realize, often discovered incidentally on an echocardiogram done for another reason. It represents a window of opportunity: starting medications that block neurohormonal activation at this stage can slow or prevent progression to symptomatic heart failure. Missing it means losing that chance to intervene early.
Physical examination is not especially sensitive at picking up systolic dysfunction before symptoms appear. The most useful bedside clues include an abnormal apical impulse (the heart’s point of maximum impact felt on the chest wall being displaced or diffuse), an enlarged heart shadow on a chest X-ray, and certain patterns on an electrocardiogram. None of these are reliable enough on their own to rule the condition in or out, which is why imaging is essential for anyone with risk factors.
How Doctors Measure Systolic Function
Echocardiography, an ultrasound of the heart, is the workhorse tool for assessing LV systolic function. It is widely available, does not involve radiation, and can be done at the bedside. The standard measurement is the ejection fraction, but cardiologists increasingly rely on a technique called global longitudinal strain (GLS), which tracks the deformation of heart muscle in finer detail. GLS can pick up early declines in contractile performance even when the ejection fraction still looks normal, making it useful for monitoring patients on cardiotoxic chemotherapy or those with valve disease.25European Heart Journal – Cardiovascular Imaging. Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging
Cardiac MRI is considered the gold standard for measuring heart volumes and ejection fraction with precision, and it has the added ability to characterize tissue, revealing scar, inflammation, or infiltration that echocardiography cannot see. However, it is more expensive, takes longer, and is not always available outside larger medical centers.26PubMed. Imaging techniques for cardiac strain and deformation: comparison of echocardiography, cardiac magnetic resonance and cardiac computed tomography In practice, echocardiography handles most routine evaluations, and cardiac MRI is reserved for cases where the diagnosis is unclear, when tissue characterization could change management, or when echocardiographic image quality is poor. The two modalities show reasonable agreement for global longitudinal strain, strengthening confidence in echocardiographic measurements for everyday clinical use.27American Heart Journal. Use of myocardial strain to assess global left ventricular function: A comparison with cardiac magnetic resonance and 3-dimensional echocardiography
Why Identifying the Cause Matters for Treatment
All forms of reduced ejection fraction share some common drug therapies, particularly the neurohormonal blockers that counteract the harmful compensatory cascade described earlier. Animal studies showed decades ago that combining drugs targeting different arms of this system, such as ACE inhibitors and aldosterone blockers, produced additive improvement in ventricular remodeling and reduced stress-hormone levels beyond what either drug achieved alone.28PubMed. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction That principle guided the development of the multi-drug regimens used today.
But beyond the shared toolkit, pinpointing the specific cause opens up targeted strategies that generic heart-failure treatment cannot provide. If the cause is a blocked artery with hibernating muscle, revascularization can restore function. If the cause is a runaway heart rhythm, ablation or rate control can reverse the cardiomyopathy entirely. If the cause is a tight aortic valve, replacement stops the mechanical overload. If the cause is anthracycline toxicity, early detection through strain imaging may allow oncologists to adjust treatment before permanent damage sets in. And if a titin gene variant is found, screening family members becomes important even if they feel perfectly well. In short, the ejection fraction tells you how bad the problem is; the cause tells you what to do about it.